FDA chief: COVID, mail mix-up delayed action on baby formula
|
May 25, 2022 10:20 AM
By MATTHEW PERRONE
AP Health Writer
WASHINGTON — The head of the Food and Drug Administration said Wednesday that efforts to investigate problems at a baby formula plant linked to the nationwide shortage were slowed by COVID-19, scheduling conflicts and even a missing piece of mail....
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login